# Exploring the potential of liver microphysiological systems of varied configurations to model cholestatic chemical effects

**Authors:** Katharina S. Nitsche, Courtney Sakolish, Paul L. Carmichael, Philip Hewitt, Piyush Bajaj, Stephen S. Ferguson, Sarah M. Lloyd, Sarah S. Wilson, Hans Bouwmeester, Ivan Rusyn

PMC · DOI: 10.1007/s00204-025-04263-1 · Archives of Toxicology · 2025-12-08

## TL;DR

This study compares different liver models to see how well they can predict cholestasis caused by chemicals.

## Contribution

The study identifies that PhysioMimix LC12 with PHH is most effective in detecting cholestatic effects.

## Key findings

- HepaRG and PHH showed comparable liver function markers in 2D and PhysioMimix LC12.
- Bile acid synthesis was highest with PHH in PhysioMimix LC12.
- Cholestatic agents reduced bile acid release only in PhysioMimix LC12, with PHH showing more consistent responses.

## Abstract

Human in vitro liver tissue models have evolved to maintain hallmarks of hepatocellular function for extended periods with potential to model aspects of cholestasis for drug and chemical safety applications. Microphysiological systems (MPS) have been suggested as promising new approaches to model liver physiology and predict chemical-induced cholestasis in humans. This study comprehensively compared both basal function and toxicant-induced effects in 2D cultures and three liver MPS (i.e., 2-lane OrganoPlate, 3-lane OrganoPlate and PhysioMimix LC12) that were seeded with either HepaRG cells, primary human hepatocytes (PHH), or human induced pluripotent stem cell (iPSC)-derived hepatocytes. PHH and iPSC-derived hepatocytes (iHeps) were tested up to 7 days while HepaRG were evaluated over 30 days. Albumin, urea, CYP3A4 activity, and bile acids were measured. HepaRG and PHH showed comparable function in 2D and PhysioMimix LC12, with albumin higher for HepaRG and urea higher for PHH. HepaRG maintained production of biomarkers for up to 30 days in both 2D and PhysioMimix LC12. In both OrganoPlate models, HepaRG produced higher levels of albumin and urea as compared to iHeps; still, HepaRG function in OrganoPlate was lower than that in 2D or PhysioMimix LC12. Bile acid synthesis (after 7 days) was much higher with PHH in the PhysioMimix LC12 as compared to 2D PHH or 2D HepaRG. Upon exposure to cholestatic agents (bosentan, 2-octynoic acid, α-naphthyl isocyanate), robust CYP3A4 induction was observed in HepaRG and PHH treated with bosentan and α-naphthylisocyanate. Only in PhysioMimix LC12, both HepaRG and PHH, all compounds elicited decreased bile acid release into cell culture medium, a biomarker for cholestasis. In summary, the hepatocyte functional markers (CYP3A4, albumin, urea) were comparable between PHH and HepaRG in 2D and PhysioMimix LC12 MPS. However, the effects of cholestatic agents on PHH and HepaRG, specifically, bile acid release were detected only in the PhysioMimix LC12 with PHH showing more consistent responses compared to HepaRG.

The online version contains supplementary material available at 10.1007/s00204-025-04263-1.

## Linked entities

- **Proteins:** CYP3A4 (cytochrome P450 family 3 subfamily A member 4)
- **Chemicals:** bosentan (PubChem CID 104865), 2-octynoic acid (PubChem CID 21872)
- **Diseases:** cholestasis (MONDO:0001751)

## Full-text entities

- **Genes:** CYP3A4 (cytochrome P450 family 3 subfamily A member 4) [NCBI Gene 1576] {aka CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** cholestasis (MESH:D002779)
- **Chemicals:** HepaRG (-), Bile acid (MESH:D001647), bosentan (MESH:D000077300), alpha-naphthyl isocyanate (MESH:C061621), urea (MESH:D014508), 2-octynoic acid (MESH:C060855)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** PHH — Homo sapiens (Human), Transformed cell line (CVCL_SA11), HepaRG — Homo sapiens (Human), Hepatitis C infection, Cancer cell line (CVCL_9720)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12967466/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12967466/full.md

---
Source: https://tomesphere.com/paper/PMC12967466